Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Clinical trial NCT05006664 · UNKNOWN

Trial details

NCT number: NCT05006664
Sponsor: Czech Lymphoma Study Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral

Start date: 2021-10-01
Primary completion: 2024-10-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.